Comprehensive Treatment of Anaplastic Thyroid Cancer
10.3971/j.issn.1000-8578.2022.21.1276
- VernacularTitle:甲状腺未分化癌的综合治疗
- Author:
Detao YIN
1
;
Pengyu ZHANG
Author Information
1. Department of Thyroid Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
- Publication Type:Research Article
- Keywords:
Anaplastic thyroid cancer;
Surgery;
Chemoradiotherapy;
Immunotherapy;
Targeted therapy
- From:
Cancer Research on Prevention and Treatment
2022;49(2):85-89
- CountryChina
- Language:Chinese
-
Abstract:
Anaplastic thyroid cancer (ATC) is a rare malignancy, accounting for 1%-2% of all thyroid cancers, however, ATC accounts for the majority of deaths from thyroid cancer. Currently, the main comprehensive treatments are surgery, radiotherapy, chemotherapy, targeted therapy and immunotherapy. Based on the latest American Thyroid Association guidelines and the related literatures, we summarize the most reasonable and effective therapeutic strategies to improve the survival rate of patients with ATC as well as the quality of life.
